CANTA, ANNALISA ROSANNA
 Distribuzione geografica
Continente #
NA - Nord America 11.141
EU - Europa 6.449
AS - Asia 4.041
SA - Sud America 204
OC - Oceania 41
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 23
Totale 21.931
Nazione #
US - Stati Uniti d'America 10.936
SG - Singapore 1.741
DE - Germania 1.316
IT - Italia 1.252
CN - Cina 1.087
SE - Svezia 969
IE - Irlanda 831
RU - Federazione Russa 561
UA - Ucraina 513
HK - Hong Kong 448
GB - Regno Unito 314
CA - Canada 191
BR - Brasile 176
FI - Finlandia 168
VN - Vietnam 152
AT - Austria 138
ID - Indonesia 126
IN - India 121
FR - Francia 107
JP - Giappone 88
KR - Corea 83
DK - Danimarca 74
NL - Olanda 55
TR - Turchia 47
BE - Belgio 42
IR - Iran 35
AU - Australia 25
PL - Polonia 24
EU - Europa 20
NZ - Nuova Zelanda 16
PK - Pakistan 15
TW - Taiwan 14
EG - Egitto 13
IL - Israele 12
RO - Romania 12
ES - Italia 10
MY - Malesia 10
IQ - Iraq 9
BD - Bangladesh 8
BG - Bulgaria 8
CH - Svizzera 8
HR - Croazia 8
MX - Messico 8
ZA - Sudafrica 8
PT - Portogallo 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
AR - Argentina 6
CZ - Repubblica Ceca 6
EC - Ecuador 5
HU - Ungheria 4
KZ - Kazakistan 4
PY - Paraguay 4
RS - Serbia 4
UZ - Uzbekistan 4
BO - Bolivia 3
CO - Colombia 3
LB - Libano 3
LT - Lituania 3
LV - Lettonia 3
MA - Marocco 3
MD - Moldavia 3
NO - Norvegia 3
PH - Filippine 3
TH - Thailandia 3
VE - Venezuela 3
A1 - Anonimo 2
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
CL - Cile 2
GT - Guatemala 2
JO - Giordania 2
KG - Kirghizistan 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
TN - Tunisia 1
UY - Uruguay 1
Totale 21.931
Città #
Ann Arbor 2.459
Singapore 1.148
Woodbridge 853
Dublin 813
Chandler 808
Frankfurt am Main 706
Houston 612
Wilmington 545
Jacksonville 535
Milan 501
Fairfield 480
Ashburn 438
Dearborn 436
Hong Kong 425
New York 349
Santa Clara 346
Princeton 282
Seattle 211
Boardman 189
Nanjing 185
Shanghai 150
Cambridge 142
Vienna 130
Jakarta 115
Beijing 100
Guangzhou 87
Lachine 84
Lawrence 80
Dong Ket 77
Altamura 74
Helsinki 67
Shenyang 60
Nanchang 59
Council Bluffs 57
Los Angeles 50
Andover 49
Carate Brianza 49
Chicago 46
Grafing 45
Toronto 44
Falls Church 42
Fremont 40
Pune 40
Nuremberg 39
San Diego 39
Nürnberg 35
Brussels 34
Jinan 34
Jiaxing 32
Rome 31
Kunming 29
Tianjin 29
Ottawa 28
Melzo 26
Norwalk 26
Changsha 25
Tokyo 25
Daejeon 24
Zhengzhou 24
Hangzhou 23
London 22
Mountain View 22
Sacramento 22
Shangdi 22
Bergamo 18
Hebei 18
São Paulo 18
Codroipo 17
Dallas 16
Hefei 15
Ningbo 15
Washington 15
Leawood 14
Lissone 14
Mainz 14
Edmonton 13
Huizen 13
Kraków 12
Seoul 12
Shinjuku 12
Taizhou 12
Auburn Hills 11
Bologna 11
Canazei 11
Lappeenranta 11
San Mateo 11
Sesto San Giovanni 11
Florence 10
Kiev 10
Paris 10
Phoenix 10
Romola 10
Cagliari 9
Kuala Lumpur 9
Rio de Janeiro 9
Wuhan 9
Fuzhou 8
Miami 8
Boston 7
Chongqing 7
Totale 15.029
Nome #
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 407
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 322
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 309
Age-related changes in the function and structure of the peripheral sensory pathway in mice 305
Enhanced brain targeting of engineered solid lipid nanoparticles 255
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 249
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 247
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 233
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 225
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 223
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 222
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 221
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 214
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 214
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 211
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 208
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain 207
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 204
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 203
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 203
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 201
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 194
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 193
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 189
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 189
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 189
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 189
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 185
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 185
A large-field polarisation-resolved laser scanning microscope: Applications to CARS imaging 183
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 182
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 180
Enhanced brain targeting of engineered solid lipid nanoparticles 180
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 180
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 179
OCT2 transporter involvement in development of cisplatin toxicity 177
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 177
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 175
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 175
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 172
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 170
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 168
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 168
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 168
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 167
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 167
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 167
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 167
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 164
The neuroprotective effect of erythropoietin (EPO) and of its non-erythropoietic carbamylated derivative (CEPO) in cisplatin-induced peripheral neurotoxicity 162
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 162
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 161
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 161
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 160
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 159
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 159
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 157
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation 157
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 156
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 153
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 153
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 150
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 148
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 144
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 144
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 143
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 143
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 143
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 142
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 141
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 141
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 138
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 138
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 138
Chemotherapy-induced allodinia: Neuroprotective effect of acetyl-L-carnitine 136
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 136
Multimodal experimental approach to the study of human neurological diseases 136
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 135
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 135
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 135
Genetic factors influencing the development of vincristine-induced neurotoxicity 135
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 134
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 133
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 132
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 132
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 131
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 130
Correlation between organic cation transporter expression in rat dorsal root ganglia neurons and cisplatin-induced peripheral neurotoxicity 130
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 130
Effect of proteasome inhibition on the central and peripheral nervous system 128
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 124
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 124
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 124
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 124
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 123
Peripheral neurotoxicity induced by cisplatin: a possible role of OCT2 gene 121
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 120
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 120
Organic cation transporters and cisplatin-induced peripheral neurotoxicity in dorsal root ganglia neurons 120
Glutamate Carboxypeptidase II inhibition in several rat models of chemotherapy-induced peripheral neurotoxicity 120
Totale 17.163
Categoria #
all - tutte 85.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.712


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020511 0 0 0 0 0 0 0 0 0 254 212 45
2020/20212.832 140 129 318 276 235 254 314 247 241 217 178 283
2021/20221.893 132 194 143 200 168 212 91 89 91 133 144 296
2022/20233.477 363 887 321 358 276 535 61 176 277 56 103 64
2023/20242.911 97 106 106 134 345 709 519 176 136 65 65 453
2024/20254.648 385 826 683 331 581 305 500 256 772 9 0 0
Totale 23.052